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An adequate intake of polyunsaturated fatty acids (PUFAs) plays a vital role in human 26 
health. Therefore, it is important to assess PUFA intakes in different populations and 27 
validate them with biomarkers, but only a few small studies are in paediatric populations. 28 
We calculated the dietary intake of PUFAs and their main food sources in children and 29 
assessed associations between PUFA intakes and plasma proportions. Dietary intakes 30 
of 7-year-old children (n=8,242) enrolled in the Avon Longitudinal Study of Parents and 31 
Children were calculated from parental-completed food frequency questionnaire. 32 
Plasma PUFAs were measured in 5,571 children 8 months later and 4,380 children had 33 
complete dietary and plasma data. The association between dietary and plasma PUFAs 34 
proportions were estimated using Spearman’s correlation coefficients, quintile cross-35 
classification and Cohen’s kappa coefficients. Mean total PUFA intake was 13.2g/day 36 
(sd4.2), contributing 6.5% of total energy intake; n-6 PUFA contributed 5.2% and n-3 37 
PUFA 0.7%. The n-6:n-3 ratio was 7.9:1. Mean intakes of eicosapentaenoic acid and 38 
docosahexaenoic acid (DHA) were 35.7mg/day and 49.7mg/day, respectively. Most n-39 
3 and n-6 PUFA intakes were weakly correlated with their respective plasma lipids 40 
(0.07≤ r ≤0.16, p<0.001). The correlation between dietary and plasma DHA was 41 
stronger though (r=0.34, p<0.001), supported by a modest level of agreement between 42 
quintiles (k=0.32). The results indicate that the FFQ was able to reasonably rank the 43 
long-chain PUFA, DHA, in this paediatric population. Public health initiatives need to 44 
address the suboptimal ratio of n-6:n-3 PUFAs and very low n-3 long-chain PUFA 45 
intakes in school-aged children in the UK. 46 
 47 





Polyunsaturated fatty acids (PUFAs) are essential for human growth and development, 50 
forming a crucial part in membrane structures and brain and retinal development during 51 
infancy (1). They may also play an important role in modulating risk of cardiovascular, 52 
inflammatory and neurodegenerative diseases (2; 3; 4). PUFAs consist of two distinct 53 
families: omega 3 (n-3) and omega 6 (n-6). The medium-chain parent fatty acids (FA), 54 
n-3 alpha-linolenic acid (ALA) and n-6 linoleic acid (LA), are termed essential because 55 
they cannot be synthesized endogenously and so need to be provided by diet. In 56 
contrast, the n-3 and n-6 long-chain (LC)-PUFAs can be derived either from the diet or 57 
endogenously synthesized from the parent PUFAs. The n-3 and n-6 PUFAs have 58 
distinct physiological functions (1; 4; 5). A low ratio of n-6 to n-3 PUFAs in the diet is 59 
important for health, since high ratios favour a pro-inflammatory state (3; 4). Modern 60 
Western diets are generally low in n-3 PUFAs, particularly in the marine LC-PUFAs 61 
(EPA and DHA) while high in n-6 PUFAs, resulting in an n-6:n-3 ratio often reaching up 62 
to 15-16:1 (6). Therefore, lowering the current ratio is recommended, since an n-6:n-3 63 
ratio of 2–3:1 is associated with reduced risk of many chronic inflammatory-related 64 
diseases (4). A high ratio of n6:n-3 PUFAs and/or inadequate EPA and DHA early in life 65 
may also be a potential risk factor for a range of neurodevelopmental cognitive 66 
disorders in childhood (7). 67 
Many countries, including the UK, have made public health recommendations to replace 68 
the consumption of saturated fatty acids (SFAs) with PUFAs (8; 9; 10; 11). The UK Scientific 69 
Advisory Committee on Nutrition (SACN) recommends that 6.5% of total energy intake 70 
should be from PUFAs (10). The European Food Safety Authority (EFSA) recommends 71 
an intake of 250 mg/day of EPA and DHA (12). However, many Western populations fall 72 
well below this intake (13; 14; 15; 16; 17; 18). Data from the nationally representative UK 73 
National Diet and Nutrition Survey (NDNS) showed that while total and n-6 PUFA 74 
intakes were in line with dietary guidelines, most children failed to meet recommended 75 
minimum weekly fish intakes (19). However, direct measures of EPA and DHA were not 76 
available. It is particularly relevant to assess adequacy of PUFA intakes in paediatric 77 
populations as suboptimal PUFA intakes early in life may modulate disease risk 78 
throughout the life course(7; 20). It is also essential to validate the tools used to assess 79 
dietary PUFA intakes, which is generally done by studying PUFA concentrations in 80 
blood and tissue (21). Numerous biomarker validation studies in adults have compared 81 




biomarkers, including FA in plasma, phospholipids, erythrocyte membranes and 83 
platelets or in adipose tissue (22; 23; 24; 25; 26). However, validation studies conducted in 84 
children are limited and mostly based on small sample sizes (n=35-404) (27; 28; 29; 30). 85 
Estimating dietary intake is particularly challenging in children and reporting error 86 
(notably under-reporting) can vary by age-group (31; 32). 87 
Therefore, the objectives of this study were to 1) assess the dietary intake and food 88 
sources of n-3 and n-6 PUFAs within a paediatric population from the UK (n=8,242); 89 
and 2) measure the correlations between PUFA intakes estimated through food 90 
frequency questionnaires (FFQ) and PUFA concentrations in plasma (n=4,380) in 91 
children from the Avon Longitudinal Study of Parents and Children (ALSPAC). 92 
Method 93 
Study cohort and participants 94 
The study participants were the core index children (first generation=G1) from ALSPAC, 95 
a transgenerational prospective birth cohort established to investigate the determinants 96 
of health and disease across the life course, including childhood development and 97 
growth. Full details of the cohort and study design have been described previously (33; 98 
34; 35) and are also available on the ALSPAC website (www.alspac.bris.ac.uk). In 99 
addition, the study website contains details of all the data that is available through a fully 100 
searchable data dictionary and variable search tool 101 
(http://www.bristol.ac.uk/alspac/researchers/our-data/).  In 1991-1992, 14,541 eligible 102 
pregnant women from the Southwest of England were enrolled into the study, resulting 103 
in 13,988 children alive at 1 year and followed since birth. During follow-up extensive 104 
data have been regularly collected on the parents and their children, primarily using 105 
questionnaires, medical records, biological samples and clinical visits. The current study 106 
uses data from the child cohort when aged 6.8±0.1 years whose parents completed a 107 
child-based FFQ in 1997–1999 (n=8,482) and from the children who took part in a 108 
research clinic at age 7.5 (SD 0.2) years and had blood samples collected and analysed 109 
(n=4,380 children had blood samples and FFQ data), see Figure 1 for study flow 110 
diagram. Ethics approval for the study was obtained from the ALSPAC Ethics and Law 111 
Committee and the Local Research Ethics Committee 112 




Declaration of Helsinki. Consent for biological samples was collected in accordance with 114 
the Human Tissue Act. 115 
Dietary data 116 
The parental-completed FFQ was adapted from the original FFQ used to assess 117 
maternal diet in ALSPAC at 32 weeks of pregnancy(36), with full details published 118 
previously(37). In summary, the questionnaire contained a series of questions enquiring 119 
about the frequency of the child’s habitual consumption of 80 different food and drinks 120 
and included questions about school meals and food items often consumed by children. 121 
The frequency ranges used were ‘never or rarely’, ‘once every 2 weeks’, ‘1-3 times a 122 
week’, ‘4-7 times a week’ and ‘more than once a day’. There were five questions directly 123 
relating to fish and seafood intake. These foods are high in n-3 LC-PUFA and thus 124 
allowed an estimate of n-3 LC-PUFA intakes particularly from fish sources. Foods 125 
normally consumed every day and in a variety of forms, such as bread, milk and fat 126 
spreads were questioned in more detail.  Standard portion sizes (38) for children in this 127 
age group were used in combination with the reported frequency of consumption of 128 
each food/drink to calculate dietary intakes. Energy and nutrients intakes were 129 
estimated using the nutrient content of foods based on 5th edition of McCance and 130 
Widdowson’s (M&W) food tables (39). The food items and portion sizes assessed for the 131 
school meal section of the FFQ were informed by school menus collected at the time 132 
from local schools. 133 
 134 
Estimation of PUFA Intake 135 
A food composition database (FCDB) was created in order to calculate the children’s 136 
intake of total, n-3 and n-6 PUFAs and individual PUFAs (linoleic acid (LA), alpha-137 
linolenic acid (ALA), arachidonic acid (AA), eicosapentaenoic acid (EPA), 138 
docosahexaenoic acid (DHA)). The PUFA composition of food items covered in the 7-139 
year FFQ was primarily determined using the electronic version of M&W food 140 
composition tables (6th edition, 2002) (40). When necessary this was supplemented with 141 
the M&W Fatty Acids Supplement  (Ministry of Agriculture Fisheries and Food [MAFF], 142 
1998) and data from the NDNS database(41). A manual matching process was employed 143 
to combine ALSPAC food codes with appropriate M&W code. If no exact match was 144 
found a similar food item close to the original was used, resulting in all foods in the FFQ 145 




Plasma Fatty Acids 147 
Plasma obtained from the non-fasting blood samples was stored at –70oC, thawed once 148 
to obtain a 100µl aliquot that was refrozen and shipped by airfreight to Rockville, MD, 149 
USA, and then thawed for final analyses (42). Plasma FAs  were extracted using 150 
transmethylation of lipids with acetyl chloride and methanol (43; 44). Chromatographic 151 
separation of the fatty acid methyl esters was achieved via fast gas chromatography 152 
6890 Plus LAN system (Agilent Technologies, USA) coupled with a fused-silica, narrow 153 
bored DB-FFAP capillary column (Agilent 127–32H2, 15m × 0.1 mm I.D. × 0.1 mm film 154 
thickness. Assays were carried out during 2009–2010 with the measurement of 22 fatty 155 
acids, 11 of which were PUFAs.  156 
Statistical Analysis 157 
Analyses were performed using SPSS (version 19, Chicago, IL, USA) and STATA 15 158 
(Statacorp, College Station, TX). A total of 240 (2.8%) of the original 8,482 participants 159 
with FFQ data were excluded from the statistical analysis due to implausible dietary 160 
data, using cut offs <15,000 and >140,000 kJ/week, based on inspecting the histogram 161 
of weekly energy intake. This gave a final study sample of 8,242 participants with valid 162 
FFQ data and 4,380 participants with both valid FFQ and blood plasma FA data. The 163 
analyses were carried in all participants and stratified by sex. The dietary and plasma 164 
PUFA data was assessed for normality and since the majority of the data was not 165 
normally distributed non-parametric tests were used (the data was not transformed). 166 
The children’s daily PUFA intake was summarised as, medians and interquartile 167 
ranges, and as a percentage of total energy intake. Plasma PUFA concentrations were 168 
presented as percentage of total FA. The contribution of dietary n-3 and n-6 PUFAs 169 
from eleven food groups was calculated and expressed as median daily intake and 170 
percentages of total PUFA intake (calculated at an individual level). These food groups 171 
encompassed all the individual food items (except soft drinks) covered in the FFQ and 172 
consisted of 1) vegetables, pulses and potatoes, 2) bread, cereals and bakery products, 173 
3) meat and meat products, 4) fish and fish products, 5) milk and milk products, 6) fat 174 
spreads and cooking fat, 7) crisps and savoury snacks, 8) nuts and seeds, 9) egg and 175 
egg dishes, 10) fruit and 11) sugar, preserves and confectionary. The contribution of 176 





The correlation between crude and energy adjusted dietary PUFA intakes and plasma 179 
PUFA proportions was assessed by Spearman’s correlation coefficients (r). PUFA 180 
intakes were not log transformed but were energy adjusted using the energy density 181 
method, by dividing each individual’s PUFA intake by their total energy intake and then 182 
multiplying by 7000 (approximately the median energy intake in kJ/day) (45). Cross-183 
classification analysis was used to evaluate agreement between the two PUFA 184 
measures. Energy adjusted dietary PUFA intakes were classified into quintiles and then 185 
cross-tabulated with quintiles of the respective PUFA plasma proportion. Discordance 186 
and agreement in quintile rankings were evaluated by calculating the percentage of 187 
participants classified in the same quintile, same or adjacent quintile, and opposite 188 
quintile. In addition, Cohen’s weighted kappa statistics (Kw) and 95% confidence 189 
intervals were calculated for quintiles of energy adjusted PUFA intakes and plasma 190 
PUFA proportions, since they consider agreements that were due to chance. The 191 
strength of the correlations (r)  and agreements (Kw) were evaluated as poor (<0·2), 192 
moderate (0·2–0·59) or good (>0·6)(46).. 193 
 194 
Results 195 
The characteristics of the 8,242 7-year-old children with FFQ data and 4,380 children 196 
with both FFQ and plasma FA data are outlined in Table 1. In the sample of 8,242 197 
children there was a mean energy intake of 7,687 (SD 1,859) kJ/day. Fat intake (75.7 198 
g/day) contributed 37.1% to total energy intake, of which 14.7% of energy was from 199 
saturated fatty acids, 11.8% from monounsaturated fatty acids and 6.5% from PUFAs 200 
(13.2 g/day). The sub-sample with both dietary and plasma FA data had a lower daily 201 
energy intake, mothers with a higher education, a higher family social class and were 202 
less overweight/obese compared to the sample with only FFQ data.  203 
Dietary and plasma PUFAs  204 
The reported intake of dietary fatty acids and proportions of plasma fatty acids 205 
(calculated as percentage of total fatty acids) is shown in Table 2, along with data on 206 
the PUFA subtypes. The majority of PUFAs were consumed in the form of n-6 PUFA; 207 
80.3% of total PUFAs and 5.2% of total energy This was mainly due to intake of LA, 208 
which contributed to a mean of 5.1% of total energy. n-3 PUFAs accounted for 10.6% 209 




intake of the DHA was 49.7 mg/day with 10% of children having less than 15 mg/day. 211 
The long-chain n-3 PUFAs (DHA and EPA) average intake was 85.4mg/day. The n-212 
6:n-3 ratio in the diet was 7.9:1.  213 
The median concentration of total fatty acids in plasma was 2.26mg/mL (1.9-2.6mg/mL 214 
for 25th and 75th percentile range). The PUFA plasma proportions were dominated by 215 
n-6 PUFAs, particularly LA (30.6% of total plasma fatty acids). AA (a long-chain n-6 216 
PUFA) contributed 6.4% of total plasma fatty acids, whereas n-3 PUFAs (ALA, DHA 217 
and EPA) contributed only 3.2% of total fatty acids and the contribution of DHA was 218 
more than twice that of either ALA or EPA. The PUFA intakes and PUFA plasma 219 
proportions are presented separately for females and males in Supplementary Tables 220 
1 and 2, respectively. Statistical comparison of PUFA intakes and plasma proportions 221 
by sex indicated differences unlikely to be explained by chance, however in absolute 222 
terms the differences were minimal. 223 
Dietary sources of PUFA intake  224 
The mean daily intakes and percentage contribution to n-6 and n-3 PUFAs and DHA 225 
intakes according to food groups are shown in Table 3 (Supplementary Table 3 for sex-226 
specific intakes). The highest intake of n-6 PUFAs was from cereal-based products and 227 
from fat spreads and cooking fat, together contributing to almost half of n-6 PUFA intake. 228 
Further important sources were fats used in vegetable and potato dishes and in meat 229 
and meat products. The main source of n-3 PUFAs was vegetable fat used in vegetable 230 
and potato dishes (28.5%), followed by cereal products, meat and meat products and 231 
milk and milk products. The major dietary source of DHA and EPA was fish (contributing 232 
to 59.2% of DHA and 45.9% of EPA intake). Other dietary sources of the LC-PUFAs in 233 
these children were meat and meat products, eggs (for DHA), and fats and spreads and 234 
milk and milk products (for EPA). Most other food groups provided no DHA or EPA. In 235 
terms of the different types of fish and seafood, coated fish contributed most to the 236 
children’s DHA and EPA intake, providing a mean of 7.9 mg/day and 6.8 mg/day 237 
respectively (Table 4). Another major source of LC-PUFAs was from oily fish and tuna 238 
(canned or fresh). School meals contributed to 10.5% and 9.5% of DHA and EPA from 239 
fish, respectively. Out of the cohort of 8,242 children, 568 (6.9%) did not consume any 240 




Validation analyses 242 
The correlation between energy adjusted dietary PUFA intakes and PUFA plasma 243 
proportions are presented in Table 5 (there were minimal differences in the correlations 244 
using crude and energy adjusted PUFA intakes so only energy adjusted results are 245 
presented). Overall, the dietary intakes of the parent n-6 and n-3 FA (LA and ALA) were 246 
weakly correlated with their respective plasma lipid concentrations (r=0.16, p<0.001 and 247 
r=0.14, p<0.001, respectively). There were also weak correlations between dietary and 248 
plasma AA and between dietary and plasma EPA (r=0.08, p<0.001 and r=0.10, p<0.001, 249 
respectively). The strongest correlation in our study was between dietary and plasma 250 
DHA (r=0.34, p<0.001), explaining around 8% of the variance. The correlations were 251 
similar when female and male participants were analysed separately (Supplementary 252 
Tables 5a and 5b, respectively). With regards to correlations between different types of 253 
PUFAs, the precursor of the n-6 series, dietary LA, was not correlated with plasma AA 254 
but it was weakly negatively correlated with plasma concentrations of EPA. For the n-3 255 
PUFAS, there were significant but weak positive correlations between dietary ALA, the 256 
precursor of the n-3 series, and EPA and DHA, and between dietary EPA and plasma 257 
DHA and vice versa.  258 
Cross-classification of quintiles of dietary and plasma PUFAs subtypes showed that 54-259 
79% of children were classified into the same or adjacent quintile, with the highest 260 
agreement for DHA (Table 6). In contrast, 3-7% of children were misclassified into the 261 
opposite quintile. Kappa statistics (Table 6) showed that for the majority of n-6 and n-3 262 
PUFAs there was poor agreement between their respective dietary and plasma 263 
measures (k<0.2). There was a moderate level of agreement between dietary and 264 




Dietary intakes of the n-6 and n-3 series of PUFAs were assessed by FFQ in 7-year-old 269 
children living in South-West England in 1999/2000 and agreement with plasma PUFA 270 
measured 8 months later were assessed. On average, PUFAs made up 6.5% of total 271 
energy intake, with the greatest proportion from n-6 PUFAs (5.2%) and only 0.7% of 272 
energy from n-3 PUFAs. This resulted in a n-6:n-3 ratio of 7.9:1. The majority of dietary 273 
n-6 PUFAs were from fat spreads and cooking fat and from cereals and cereal-based 274 




correlations between dietary PUFAs and their corresponding plasma concentrations in 276 
blood. However, dietary DHA and plasma DHA concentrations had a moderate 277 
correlation and a reasonable level of agreement. 278 
In this study the intakes of n-6 and n-3 PUFAs, as well as total fat, MUFAs and SFA, 279 
were very similar to NDNS (1997) intake data on 4–10-year-old children (19). The amount 280 
in g/day or percentage of energy from main PUFA subtypes (n-3, n-6, LA, AA, ALA, 281 
DHA and EPA) were also comparable with those reported in other studies of PUFA 282 
intakes in paediatric populations in Westernised countries(13; 14; 15).  However, the n-6:n-283 
3 ratio (7.9:1) was generally lower than reported in these studies which could be due to 284 
the higher estimated n-3 PUFA intakes we observed (1.4 g/day compared with 0.88–285 
1.3 g/day (14; 15; 19)). The low intakes of DHA and EPA observed in our study are also 286 
consistent with research in paediatric populations from other countries (13; 14; 15; 18).  287 
The main food groups contributing to n-3 and n-6 PUFA intakes were very similar 288 
between the current study and the NDNS study of 4–10-year-olds (19). However, we 289 
found that fat spreads and cooking oils, and cereal products contributed most to n-6 290 
PUFA intake, while in the NDNS study fats used in vegetable and potato dishes were 291 
the main source. As expected, fish and seafood dishes were the most important sources 292 
of LC-PUFAs, contributing to 59% of total DHA intake, which was comparable with 293 
previous findings (13; 14). According to the NDNS 2008–2012 rolling programme, white 294 
fish (including coated white fish) is the most common type of fish consumed in UK 6–295 
11-year-olds (average intake is four times that of oily fish) (17). Therefore, although white 296 
fish have much lower concentrations of EPA and DHA than oily fish, because of its more 297 
frequent consumption it formed the major source of LC-PUFAs in these children 298 
(contributing to 51.9% of EPA and 40.6% DHA from total fish intake). Oily/fatty fish were 299 
an important source of dietary LC-PUFAs though, consistent with findings from other 300 
studies in children (13; 16). 301 
The mean daily intake of dietary PUFAs in these 7-year old children was in line with the 302 
SACN UK recommendation of 6.5% of total energy (TE) (10; 47). LA, the principal source 303 
of n-6, provided 5.1% of TE in this cohort, also within the guidelines of ≥4% of TE set 304 
by EFSA (12). In terms of n-3 PUFA dietary recommendations, the UK advocates that it 305 
forms a minimum of 0.2% of food energy, while the Food and Agriculture Organisation 306 
and World Health Organisation (FAO/WHO) set an acceptable distribution range of 0.5–307 
2.0% of TE(18). EFSA recommends that ≥0.5% of TE should come from the n-3 PUFA 308 




TE) in our study were within these dietary recommendations. However, the dietary 310 
intakes of the LC-PUFAs in our study (85.4 mg/day) fell far below recommendations of 311 
200–250 mg/day set by internationally recognised organisations (12; 18; 47). In fact, none 312 
of the children in our cohort reached this level of intake and most children consumed 313 
less than half. This is not surprising considering the recent findings from the NDNS, 314 
which reported that only 4.7% of UK children met the minimum recommendations for 315 
fish intake and only 4.5% met minimum recommendations for oily fish (17). 316 
Encouragingly, previous studies in children have shown that even eating a small amount 317 
of fish can significantly improve LC-PUFAs levels compared with non-consumers (48).  318 
The ratio of n-6:n-3 PUFAs in our study (7.9:1) is higher than what is considered for 319 
optimal growth and long-term health (1), particularly cardiovascular health (3; 4; 49). This 320 
ratio is a reflection of the abundance of food sources of LA in modern Western diets (13; 321 
14), with regular use of fat spreads (margarines) and vegetable oils rich in LA (i.e. 322 
sunflower and corn oil) and their wide use in processed cereal-based products (baked 323 
goods and savoury and sweet snacks). In contrast, there are relatively fewer food 324 
sources high in n-3 PUFAs. To improve the PUFA balance a change in dietary habits is 325 
necessary, by increasing consumption of n-3 PUFAs and/or decreasing consumption of 326 
n-6 PUFAs. The advantage of decreasing n-6 PUFA intakes is that it potentiates the 327 
use of essential n-3 PUFAs, since LA and AA compete for the same elongase and 328 
desaturase enzymes (50). A higher intake of n-3 and LC-PUFAs can be achieved by 329 
increasing consumption of foods containing DHA and EPA (mainly fish and seafood) 330 
and/or foods containing their precursor, ALA. Although findings from the NDNS rolling 331 
programme comparing intake data from 1997 to 2008/9 in 4–10-year-olds indicate there 332 
was an overall shift towards recommended dietary guidelines for fat intakes, including 333 
an increase in consumption of n-3 PUFAs, these related to relatively small increases in 334 
absolute terms (19). 335 
Our results showed weak-to-moderate correlations between dietary and plasma 336 
PUFAs, consistent with results from previous studies comparing dietary PUFA intakes 337 
with tissue biomarkers in adults (23; 24; 26; 51) and paediatric populations (27; 28; 29; 30; 52). A 338 
study of 0–11-year-olds from the USA compared FFQ estimates with the PUFA content 339 
of erythrocyte membranes and reported a correlation of 0.16 (p<0.001) for n-6 PUFAs, 340 
0.25 (p=0.001) for n-3 PUFAs and 0.38 (p<0.001) for total marine PUFAs (30), which is 341 
comparable to the correlations of these PUFA subtypes observed in our study. An 342 




total dietary n-3 PUFAs (r=0.22) and EPA (r=0.24) and their respective concentrations 344 
in erythrocyte membranes but no correlation with DHA (27). Two studies in children 345 
observed higher correlations than in this study between dietary and tissue PUFAs for 346 
total n-6 and LA (r ranging from 0.3 to 0.4) (27; 28). The different correlations reported 347 
between studies could be partly due to variations in the type of biomarker medium, 348 
dietary assessment method, period between obtaining dietary intake and biomarker 349 
tissue, health status of study population and genetic and lifestyle factors.  350 
The overall weak-to-moderate correlations between dietary intakes of PUFAs and their 351 
respective biomarkers observed in many studies, including ours, could be explained by 352 
the fact that tissue PUFAs represent the interplay between dietary intakes, individual 353 
variation in absorption rates and metabolism. Metabolic processes and the complex 354 
interrelationships between different PUFAs along the biosynthetic pathway of 355 
elongation and desaturation is a key reason why dietary intakes may not map directly 356 
onto plasma concentrations.  357 
The weak correlations between 18-carbon chain PUFA intakes and plasma levels is in 358 
line with research in humans showing that the 18-carbon chain PUFAs are largely 359 
oxidized (53).  An experimental study using tracers in rats supports this and found that in 360 
addition to oxidation, 18-chain PUFAs move out of circulating blood lipids quickly and 361 
are stored in adipose tissue (54).  This could explain why blood 18-chain PUFAs are not 362 
good indicators of dietary intake. In addition, the association between PUFA intakes and 363 
their biomarkers may differ for shorter versus longer chain PUFAs. A systematic review 364 
of adult studies comparing FFQ estimated long-chain n-3 PUFA intake with plasma 365 
concentrations reported correlations in the range of 0.30–0.50 for DHA but only 0–0.28 366 
for ALA (22). Several studies in children have also found that correlations between 367 
PUFAs in erythrocyte membranes, serum or plasma were generally higher for the 368 
marine-origin n-3 PUFAs(27; 28; 29; 30). In our study the correlations between the shorter-369 
chain PUFAs (LA and ALA) were generally weaker than the LC-PUFAs. Shorter-chain 370 
PUFAs may be less correlated with their tissue biomarkers because they are also 371 
converted into longer-chain PUFAs, although this may only happen when concurrent 372 
intake of LC-PUFAs is low (55). ALA was not associated with plasma EPA and DHA in 373 
our study though, which is consistent with the poor endogenous conversion rate of ALA 374 
to DHA and EPA (with maximum conversion rates of 4% and 8%, respectively) (3). 375 
Consequently, tissue and circulating LC-PUFAs are mainly a reflection of their direct 376 




and level of agreement (according to Cohen’s Kappa) between dietary and plasma 378 
DHA. Indeed, in adult populations with high fish intakes, such as Japan, correlations of 379 
up to 0.60-0.70 for EPA and DHA have been observed (56; 57).  380 
Our data showed some, although weak, evidence that dietary intakes of LA were 381 
associated with lower plasma concentrations of EPA. This is in line with the evidence 382 
indicating that higher concentration of LA inhibits the conversion of ALA to EPA. 383 
Inhibition occurs because the metabolic pathway involved in converting the PUFA 384 
precursors ALA and LA to their respectively metabolites uses the same rate limiting 385 
enzyme, delta-6 desaturase(50). Intervention studies have also demonstrated that high 386 
intakes of LA were associated with lower conversion of ALA to EPA in subjects on diets 387 
without fish(58; 59).  388 
The strengths and weaknesses of the study should be considered when interpreting 389 
these results. The strengths include the large number of children with both dietary and 390 
biomarker data, making this one of the largest correlation studies of this type in children. 391 
The majority of studies validating dietary assessment tools in children in the UK have a 392 
sample size of <50(60). The use of a parental-completed FFQ specially designed for this 393 
age group enabled us to capture habitual dietary intakes, which is particularly 394 
advantageous when collecting information on foods such as fish and seafood, which 395 
are typically eaten less frequently in this population. We also had a complete database 396 
on quantities of EPA and DHA in the foods consumed, and data on intakes of these 397 
nutrients is limited in paediatric populations from the UK. However, we didn’t calculate 398 
intake of docosapentaenoic acid (DPA) or its concentration in plasma: recent findings 399 
suggest that DPA could be just as important as EPA and DHA in terms of health benefits 400 
linked to LC-PUFAs (61). Finally, the FFQ included five specific questions covering fish 401 
and seafood consumption that enabled us to assess the types of fish contributing to the 402 
LC-PUFA intake in these children.  403 
In terms of study limitations, at birth these children were relatively representative of the 404 
population in the area (33). However, sample attrition during the 7-year follow-up is likely 405 
to have produced loss to follow-up bias and it is probable that children with less healthy 406 
dietary patterns were under-represented which may in turn have influenced average 407 
PUFA intakes. However, the average PUFA intakes (as well as total fat, MUFAs, SFA) 408 
and their main food sources reported in our study were very similar to the NDNS data 409 
on nationally representative UK 4–10-year-olds. Further attrition and subsequent bias 410 




at the research clinic agreed to this and these children had a lower BMI and energy 412 
intake and had a higher socio-economic status. Nevertheless, this should not have 413 
affected the correlation results, as these analyses were within subject. The use of 414 
parental-reported FFQ to assess children’s dietary intake would be subject to issues of 415 
reporting error and bias, as with all dietary survey methods to different extents(60). To 416 
minimise this, the analysis excluded children with implausible dietary intakes.  417 
A further limitation is that the FFQ, which was designed to assess habitual dietary 418 
intake, was completed approximately 8 months prior to the blood sample being 419 
obtained. However, plasma FAs are an immediate biomarker which reflect intake over 420 
the past few days or meals (62). The choice of medium for FA biomarker measurement 421 
is relevant because they reflect FA intakes over different time periods and so should 422 
ideally be time integrated with the dietary intake period being measured (21). Erythrocyte 423 
membranes reflect intake aggregated over approximately 4 months. However, two 424 
studies in paediatric populations that compared FFQ-estimated PUFA intakes with 425 
PUFA levels in erythrocyte membranes reported similar ranges of correlations 426 
coefficient to our study (27; 30). In addition, eating habits have been shown to be 427 
reasonably stable during childhood, with moderate tracking levels (63). NDNS data on 428 
the time trends in n6 and n3 fatty acids in UK 7-9 year old children show there are 429 
minimal differences in intakes over this period in childhood (64). 430 
The difference in reference period between the FFQ and biomarker assessment could 431 
mean that the observed correlations were an underestimation of the true correlations 432 
(26). The storage time of the samples is also a potential limitation, due to oxidation of 433 
PUFAs and deterioration of lipid classes over time(65). In our study, the samples were 434 
stored at -70oC for approximately 10 years before the plasma FA composition was 435 
analysed. However, plasma FAs are considered to be relatively stable for up to 10 years 436 
with such ultracold storage (64; 65). This also supports our choice of pool sample (plasma) 437 
in place of erythrocytes; although erythrocytes are less influenced by recent dietary 438 
intake, the FA composition is not completely stable during their 4-month lifespan, since 439 
the FAs in the membranes can remodel with recent diet intake and the haem content of 440 
erythrocytes can cause PUFA oxidation (65).  441 
A final limitation is the food composition database used to estimate intakes from the 442 
FFQ data. The composition of foods and types of food available change with time (for 443 
example omega-3-enriched foods are now more readily available). Food composition 444 




they update food composition data. However, we supplemented the M&W food 446 
composition tables with up-to-date data from other sources in order to maximise the 447 
completeness of the PUFA composition of the foods covered in our FFQ.  448 
In conclusion, the weak to moderate correlations between dietary and plasma LC-PUFA 449 
intakes and good level of agreement in cross-classification analysis reflect the ability of 450 
the parental-completed FFQ to relatively rank the LC-PUFA intakes in this paediatric 451 
population, particularly for DHA. Our results highlight the need for public health 452 
initiatives to address the suboptimal ratio of n-6:n-3 PUFAs and very low n-3 LC-PUFAs 453 
in school-aged children in the UK. The optimal dietary approach to increase tissue LC-454 
PUFAs and to reach recommended intakes is to consume them directly in their 455 
preformed state, mainly from sustainably sourced fish (particularly oily fish) and 456 
seafood, but also from lean (red) meat, eggs and products nutritionally enriched with 457 
LC-PUFAs. For children unable or reluctant to eat fish or seafood, then dietary changes 458 
that reduce foods high in LA (i.e. sunflower and corn oil and cereal-based processed 459 
products) while increasing foods rich in ALA (i.e. rapeseed and flaxseed oil, nuts, green 460 
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Figure 1. Study flow diagram for participant data from the Avon Longitudinal Study of 







Table 1: Characteristics and daily nutrient intakes of the 8,242 7-year- old children from 
ALSPAC with dietary data compared with the 4,380 with both plasma and dietary data. 
            
Characteristic  
Sample with FFQ data 
(n=8,242) 
Sample with FFQ 
and plasma fatty 
acid data (n=4,380) 
P-value1 
  n (%) n (%)   
Gender, male 4,225 (51.0) 2,266 (52.0) 0.360 
BMI, overweight/ obese (kg/m2) 1,035 (16.1) 650 (14.9) <0.001 
Maternal educational status            
Low status (none, CSE, vocational) 1,902 (23.7) 851 (19.7)   
Medium status (O-Level) 2,841 (35.4) 1,531 (35.2)   
High status (A-level and degree) 3,277 (40.9) 1,941 (45.0) <0.001 
Highest household social class           
Grade I and II (highest) 2,203 (28.9) 1,262 (30.40)   
Grade III (manual and non-manual) 4,126  (54.0) 2,215 (53.4)   
Grade IV and V (lowest) 1,307 (17.1) 675 (16.3) 0.002 
  Mean  (SD) Mean (SD)   
Total Energy, KJ/day 7,687 (1,859) 7,627 (1,763) 0.002 
Carbohydrate intake           
  g/day 238.9 (59.8) 237.1 (56.5) 0.003 
  % energy 51.9 (3.8) 52.0 (3.8) 0.487 
Protein intake           
   g/day 65.1 (16.4) 64.8 (15.8) 0.053 
  % energy 14.2 (1.8) 14.2 (1.8) 0.163 
Total Fat intake, g/day           
   g/day 75.7 (20.3) 75.1 (19.4) 0.001 
% energy 37.1 (3.5) 37.0 (3.5) 0.234 
SFA, g/day           
  g/day 30.1 (9.2) 29.8 (8.8) 0.002 
  % energy 14.7 (2.5) 14.7 (2.4) 0.307 
MUFA, g/day           
  g/day 24.2 (6.5) 23.9 (6.2) <0.001 
  % energy 11.8 (1.2) 11.8 (1.2) 0.008 
PUFA, g/day           
  g/day 13.2  (4.2) 13.1 (4.0) 0.148 
  % energy 6.5 (1.4) 6.5 (1.4) 0.195 
Abbreviations: FFQ, Food frequency Questionnaire. SD, Standard Deviation. BMI, Body Mass Index. 
CSE, Certificate of Secondary Education. SFA, Saturated fatty acid. MUFA, Monounsaturated fatty 
acids. PUFA, Polyunsaturated fatty acids. 
1P-value comparing difference between sample with both FFQ and plasma FA data and sample with 





Table 2. Daily dietary intakes of fatty acids estimated from a FFQ and plasma fatty acid 
proportions in 7-year old children from ALSPAC.  
Fatty Acids (total and sub-types) Mean (SD) Median (IQR) 
Mean (SD)    % 
of energy 
Dietary intake (n=8,242) 
Total fatty acids, g/day 75.7 (20.3) 73.9 (62.2-87.4) 37.1 (3.5) 
Saturated fatty acids, g/day 30.1 (9.2) 29.0 (23.8-35.3) 14.7 (2.5) 
Monounsaturated fatty acids, g/day 24.2 (6.5) 23.5 (19.7-27.9) 11.8 (1.2) 
Polyunsaturated fat (PUFA), g/day 13.2 (4.2) 12.8 (10.3-15.8) 6.5 (1.4) 
n-6 PUFA, g/day 10.6 (3.5) 10.3 (8.2-12.8) 5.2 (1.2) 
18:2 n-6 (LA), g/day  10.30 (3.4) 10.0 (7.9-12.4) 5.1 (1.2) 
20:4 n-6 (AA), g/day 0.05 (0.02) 0.05 (0.04-0.06) 0.02 (0.02) 
n-3 PUFA, g/day 1.4 (0.4) 1.3 (1.1-1.7) 0.7 (0.1) 
18:3 n-3 (ALA), g/day 1.3 (0.4) 1.2 (1.0-1.5) 0.6 (0.1) 
22:6 n-3 (DHA - total), mg/day 49.7 (44.8) 38.1 (23.0-60.9) 0.025 (0.02) 
22:6 n-3 (DHA - from fish only), 
mg/day 
35.0 (42.2) 20.5 (11.9-43.1) 
0.017 (0.02) 
20:5 n-3 (EPA - total), mg/day 35.7 (26.6) 29.2 (20.6-42.5) 0.018 (0.01) 
20:5 n-3 (EPA - from fish only), 
mg/day 
19.5 (24.5) 12.2 (6.5-24.4) 
0.010 (0.01) 
LC n-3 PUFA (EPA+DHA), mg/day 85.4 (70.4) 66.5 
(45.2-
102.7) 0.042 (0.03) 
Total n-6 / Total n-3  7.9 (2.3) 7.4 (6.3-9.0) 7.9 (2.3) 
Plasma proportion, % of total fatty 
acids (n=4,380) 
          
Saturated fatty acids 29.3 (3.2) 29.6 (27.4-31.5) - 
Monounsaturated fatty acids 26.9 (3.2) 26.7 (24.8-28.8) - 
n-6 Polyunsaturated fatty acids 39.8 (3.9) 39.9 (37.3-42.4) - 
n-3 Polyunsaturated fatty acids 3.9 (0.8) 3.8 (3.4-4.3) - 
18:2 n-6 (LA)  30.6 (3.2) 30.7 (28.6-32.7) - 
20:4 n-6 (AA) 6.4 (1.3) 6.4 (5.5-7.3) - 
18:3 n-3 (ALA) 0.7 (0.3) 0.7 (0.5-0.8) - 
22:6 n-3 (DHA) 1.9 (0.5) 1.8 (1.5-2.3) - 
20:5 n-3 (EPA) 0.6 (0.2) 0.6 (0.5-0.7) - 
Abbreviations: PUFA, Polyunsaturated fatty acids. SD, Standard Deviation. QR, Quartile Range 
(25th percentile-75th percentile). n-6, omega-6 series. n-3, omega-3 series. LA, Linolenic acid. AA, 
Arachidonic acid. ALA, Alpha-linolenic acid. DHA, Docosahexaenoic acid. EPA, Eicosapentaenoic 








Table 3. Daily intake and percentage contribution of total n-6, total n-3 PUFA, DHA and EPA intakes by food group estimated from a parental-
completed food frequency questionnaire when the child was aged 7 years (n=8,242). 
 
Mean (sd) % 
daily total n-6
Mean (sd) daily 
% total n-3
Mean (sd) % 
daily total DHA
Mean (sd) % 
daily total EPA
Vegetables and potatoes 1.45 (1.0-2.2) 16.5 (8.5) 0.37 (0.3-0.5) 28.5 (8.8) 0.00 (0.0-0.0) 0.0 0.32 (0.2-0.3) 1.2 (1.8)
Cereal and cereal products 2.31 (1.7-3.0) 23.5 (8.2) 0.27 (0.2-0.4) 20.7 (6.9) 0.11 (0.0-0.3) 1.9 (7.8) 0.56 (0.4-0.7) 2.5 (4.0)
Meat and meat products 1.61 (1.2-2.2) 16.7 (7.6) 0.24 (0.2-0.3) 18.7 (7.6) 6.52 (5.4-8.5) 21.2 (17.6) 2.77 (2.1-3.9) 11.1 (8.9)
Fish and fish dishes 0.58 (0.2-0.6) 4.4 (3.2) 0.06 (0.0-0.1) 5.8 (5.7) 20.50 (11.9-43.1) 59.2 (24.4) 12.23 (6.5-24.4) 45.9 (23.0)
Milk and milk products 0.39 (0.3-0.5) 4.3 (2.4) 0.15 (0.1-0.2) 12.5 (5.9) 0.00 (0.0-0.0) 0.0 (0.0) 3.30 (3.2-8.8) 14.7 (13.0)
Fat and spreads 2.47 (0.6-3.7) 22.4 (15.9) 0.08 (0.0-0.2) 6.9 (6.6) 0.00 (0.0-0.4) 0.9 (4.2) 6.93 (1.4-11.6) 21.4 (18.3)
Crisps and savoury snacks 0.32 (0.3-0.9) 5.9 (4.2) 0.03 (0.0-0.1) 4.2 (3.0) 0.00 (0.0-0.0) 0.0 (0.0) 0.00 (0.0-0.0) 0.0 (0.0)
Nuts and seeds 0.00 (0.0-2.2) 2.8 (5.7) 0.00 (0.0-0.0) 0.3 (0.7) 0.00 (0.0-0.0) 0.0 (0.0) 0.00 (0.0-0.0) 0.0 (0.0)
Egg and egg dishes 0.08 (0.0-0.3) 1.8 (2.0) 0.01 (0.0-0.0) 1.0 (1.1) 3.74 (1.1-12.2) 16.6 (17.7) 0.44 (0.0-1.7) 3.1 (4.1)
Fruit 0.00 (0.0-0.0) 0.1 (0.1) 0.00 (0.0-0.1) 0.7 (1.0) 0.00 (0.0-0.0) 0.0 (0.0) 0.00 (0.0-0.0) 0.0 (0.0)
Sugar, preserves and 
confectionary
0.10 (0.1-0.2) 1.6 (1.7) 0.00 (0.0-0.1) 0.4 (0.4) 0.00 (0.0-0.0) 0.0 (0.0) 0.00 (0.0-0.0) 0.0 (0.0)
Total 10.3 (8.2-12.8) 100 1.33 (1.1-1.7) 100 38.10 (23.0-60.9) 100 29.2 (20.6-42.5) 100
Abbreviations: IQR, Inter-quartile range (25th percentile-75th percentile). n-6, omega-6 series. PUFA, Polyunsaturated fatty acids. n-3, omega-3 series. SD, Standard 
Deviation. DHA, Docosahexaenoic acid. EPA, Eicosapentaenoic acid. 
Food group
Long-Chain PUFA intake









N-6 PUFA intake                         
total







Table 4. Contribution of different types of fish to DHA intake estimated from a  












Shellfish 0.27 (0.9) 1.0 (4.9) 0.40  (1.4) 2.1 (7.5)
Coated fish 7.85 (5.9) 40.6 (34.2) 6.80 (1.5) 51.9 (33.7)
White fish 5.24 (10.0) 12.4 (20.1) 2.65 (5.0) 11.6 (18.8)
Tuna (tinned and fresh) 8.31 (12.3) 22.4 (27.6) 1.43 (2.1) 10.7 (18.1)
Oily/fatty fish 11.32 (31.1) 13.1 (26.1) 7.30 (20.2) 14.2 (28.0)
School meal fish 2.87 (4.4) 10.5 (20.1) 1.00 (1.5) 9.5 (18.9)
Total FA from fish 35.00 (42.2) 100 19.50 (24.5) 100
Abbreviations: DHA, Docosahexaenoic acid. SD, Standard Deviation. EPA, 
Eicosapentaenoic acid. 
DHA  EPA   








Table 5. Spearman's Correlation Coefficients (r) between plasma concentations and energy adjusted dietary intakes of n-3  
and n-6 PUFAs (n=4,380) 
                        
Dietary PUFA  
Plasma PUFA    
n-6 FA     n-3 FA   
18:2  (LA) p-value 20:4  (AA) p-value   18:3  (ALA) p-value 20:5  (EPA) p-value 22:6  (DHA) p-value 
Total PUFA 0.163 <0.001 0.013 0.388   0.003 0.830 -0.140 <0.001 0.011 0.488 
Total n-6 0.161 <0.001 0.012 0.448   -0.001 0.956 -0.149 <0.001 -0.022 0.145 
18:2 n-6 (LA) 0.162 <0.001 0.011 0.465   -0.004 0.813 -0.151 <0.001 -0.024 0.117 
20:4 n-6 (AA) -0.056 <0.001 0.079 <0.001   0.077 <0.001 0.149 <0.001 0.197 <0.001 
Total n-3 0.003 0.862 0.023 0.137   0.138 <0.001 0.114 <0.001 0.170 <0.001 
18:3 n-3 (ALA) 0.010 0.491 0.003 0.843   0.138 <0.001 0.086 <0.001 0.113 <0.001 
20:5 n-3 (EPA) 0.046 0.002 0.031 0.043   0.018 0.223 0.102 <0.001 0.266 <0.001 
22:6 n-3 (DHA) 0.030 0.044 0.057 <0.001   0.052 <0.001 0.123 <0.001 0.341 <0.001 
Abbreviations: FA, Fatty Acids; LA, Linoleic acid; AA, Arachidonic acid; ALA, Alpha-linolenic acid; DHA, Docosahexaenoic acid; EPA, 
Eicosapentaenoic acid 







Table 6. Dietary PUFA intakes classified into quintiles, compared to quintiles of plasma PUFA  
proportions, with corresponding Cohen’s kappa coefficients (n=4,380) 
              
Dietary1 and 








Cohen's Kappa (K) 
Cohen's K2 (95% CI) P-value 
Total n-6 22 56 6 0.122 (0.09-0.14) <0.001 
18:2 n-6 (LA) 24 58 6 0.155 (0.13-0.18) <0.001 
20:4 n-6 (AA) 23 56 7 0.079 (0.05-0.11) <0.001 
Total n-3 23 59 5 0.185 (0.16-0.21) <0.001 
18:3 n-3 (ALA) 23 57 6 0.125 (0.10-0.15) <0.001 
20:5 n-3 (EPA) 22 54 6 0.096 (0.07-0.12) <0.001 
22:6 n-3 (DHA) 43 79 3 0.319 (0.29-0.35) <0.001 
Abbreviations: PUFA, Polyunsaturated Fatty Acids; LA, Linoleic acid; AA, Arachidonic acid; ALA, Alpha-linolenic acid; 
DHA, Docosahexaenoic acid; EPA, Eicosapentaenoic acid 
1Dietary PUFA intakes are energy adjusted using the energy density method. 2Cohen's Kappa analysis using 
weighted Kappa statistic (k) 
 
